This is unpublished TarGut: Targeting Gut Microbiome in ESRD Jonathan Himmelfarb, MD Completed Studies Dialysis Pinned Principal Investigator Jonathan Himmelfarb Funding Agency NIDDK Status Completed Investigator Jonathan Himmelfarb, MD What is the TarGut Study? This study aims to evaluate the safety, tolerability, and feasibility of administering p-inulin to the gut microbiome of ESRD patients who are undergoing hemodialysis.
